Document Detail


Premedication for non-emergency intubation in the neonate.
MedLine Citation:
PMID:  21089721     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Endotracheal intubation is frequently performed in neonatal intensive care. This procedure is extremely distressing and painful, and it has the potential for causing laryngospasm, hemodynamic changes, a rise in intracranial pressure and a risk of hemorrhage and airway injury. These adverse changes can be attenuated by using premedication with analgesic, sedative and muscle-relaxant drugs. Premedication is standard practice for pediatric and adult Intubation, but in neonates the use of supportive pharmacological measures is still hotly debated, mainly in terms of the risks and benefits of using sedatives in unstable and premature newborn. In a recent UK survey, 90% of tertiary neonatal units reported the routine use of sedation prior to intubation with a combination of atropine plus an opioid (morphine or fentanyl), while 82% of such units routinely use a muscle-relaxant. In Italy, a recent survey (in press) showed that the majority of NICU (Neonatal Intensive Care Units) use the sa me association of drugs for analgesia and sedation before tracheal intubation, but "not always" in more than half of these units. There is clearly a persistent concern about using such drugs in preterm and newborn infants, despite recent evidence showing that premedication for elective neonatal intubation is safer and more effective than when the infant is awake. Here we review the effects of using analgesic and sedative drugs on intubation conditions (good jaw relaxation, open and immobile vocal cord, suppression of pharyngeal and laryngeal reflex), on the time it takes to complete the procedure successfully, on pain control and the potentially adverse effects of using combinations of drugs for sedation.
Authors:
P Lago
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Minerva pediatrica     Volume:  62     ISSN:  0026-4946     ISO Abbreviation:  Minerva Pediatr.     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-11-22     Completed Date:  2010-12-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0400740     Medline TA:  Minerva Pediatr     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  61-3     Citation Subset:  IM    
Affiliation:
MICU, Department of Pediatrics, University of Padua, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Analgesics / administration & dosage,  therapeutic use*
Bradycardia / etiology,  prevention & control
Drug Interactions
Drug Utilization
Humans
Hypertension / etiology,  prevention & control
Hypnotics and Sedatives / administration & dosage,  therapeutic use*
Infant, Newborn
Intensive Care, Neonatal
Intracranial Hypertension / etiology,  prevention & control
Intubation, Intratracheal / adverse effects*
Italy
Laryngismus / etiology,  prevention & control*
Laryngoscopy / adverse effects
Neuromuscular Agents / administration & dosage,  therapeutic use*
Pain / etiology,  prevention & control*
Premedication*
Chemical
Reg. No./Substance:
0/Analgesics; 0/Hypnotics and Sedatives; 0/Neuromuscular Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Neonatal pain and oxidative stress.
Next Document:  Aminoterminal B-type natriuretic peptide (NT-proBNP) in the therapy of patent ductus arteriosus.